Carregant...
Fitxers
Embargament
Document embargat fins el 2099-12-31Tipus de document
ArticleData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/193490
In vivo sensitization to gliadin by oral administration
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Celiac disease is a highly prevalent immune-mediated enteropathy that develops in genetically susceptible individuals expressing HLA-DQ2 or HLA-DQ8 after ingestion of gluten and results in decreased quality of life and increased morbidity. This pathology is triggered by immunogenic peptides generated from gliadins present in gluten, which act on the intestinal mucosa in a context of high intestinal permeability, activating the innate and adaptive response of the immune system. Several in vivo rodent models attempt to reproduce some phases of the intestinal inflammatory process that occurs in celiac disease. Allergic sensitization to gluten simulates, or enhances in some animal models, the loss of tolerance to gliadin peptides and the initial events that lead to celiac disease in a specific genetic or environmental context. Here we describe a simple method for performing gliadin sensitization in an in vivo animal model.
Matèries
Matèries (anglès)
Citació
Citació
ROMERO ROMERO, María del mar, SERRA I CUCURULL, Dolors, CASTELLANOS-RUBIO, Ainara, HERRERO RODRÍGUEZ, Laura. In vivo sensitization to gliadin by oral administration. _Methods in Cell Biology_. 2022. [consulta: 22 de febrer de 2026]. ISSN: 0091-679X. [Disponible a: https://hdl.handle.net/2445/193490]